Skip to main content
. 2019 Oct 10;106(2):119–126. doi: 10.1136/heartjnl-2019-315307

Figure 1.

Figure 1

Flow diagram of study population for adherence and persistence analyses. AF, atrial fibrillation; OAC, oral anticoagulant; VKA, vitamin K antagonist.